Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMLODIPINE AND OLMESARTAN MEDOXOMIL

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Standard Dose
EQ 10MG BASE;20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AMLODIPINE AND OLMESARTAN MEDOXOMIL is listed in Drugs@FDA under application 209600 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Form and strength TABLET;ORAL - EQ 10MG BASE;20MG Sponsor ACCORD HLTHCARE INC Submission history Latest submission status date: 2025-05-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLODIPINE AND OLMESARTAN MEDOXOMIL is listed in Drugs@FDA under application 209600 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Form and strength TABLET;ORAL - EQ 10MG BASE;20MG Sponsor ACCORD HLTHCARE INC Submission history Latest submission status date: 2025-05-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.